I maintain a buy rating on MSCI due to improving buy-side sentiment, strong fund inflows, and growth in ESG and private assets.

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

We recently compiled a list of the 10 Trending AI Stocks on Investors’ Radar. In this article, we are going to take a look at ...

Analyst Michael Kaye of Wells Fargo reiterated a Buy rating on PennyMac Financial (PFSI – Research Report), with a price target of ...

Kotak wrote in its note that Swiggy is a new-age, technology-driven company offering hyperlocal services such as food ...

The near term technicals are highly bullish as the chart, moving averages, and indicators show that the outlook is strong.

Staszak has a bullish outlook on chicken demand in emerging markets as well. Argus has a "buy" rating and $60 price target for PPC stock, which closed at $45.53 on Jan. 13. Sun Life Financial is a ...

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

CFRA analyst Zachary Warring reaffirmed a Buy rating and a SEK180.00 price target for Hennes & Mauritz AB (ST:HMb) (HMB:SS) (OTC: HNNMY). Warring's valuation is based on 21.2 times the firm's fiscal ...

CDNS stock currently trades at around $234 and analysts hold a consensus price target of $253.34 for the stock with a Buy rating. Its software niche and innovation have helped Cadence maintain its ...

Investors might want to bet on Qualcomm (QCOM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...